How Much Does Rapamycin (Sirolimus) Cost in Arizona in 2026?

Arizona Retail Pharmacy Pricing for Sirolimus in 2026

The average cash-pay price for generic sirolimus across Arizona retail pharmacies is approximately $80 per month as of 2026. That figure reflects a 30-day supply of 1 mg tablets at major chains like CVS, Walgreens, and Costco locations in Phoenix, Tucson, Scottsdale, and Mesa.

Prices vary by pharmacy and tablet strength. A 0.5 mg tablet may cost less per unit, but most prescriptions written for off-label longevity protocols call for 1 mg tablets taken once weekly, which brings the effective monthly cost down further when only 4 to 5 tablets are dispensed per cycle. For transplant patients taking sirolimus daily, monthly costs scale proportionally. Costco pharmacies in Arizona have historically offered some of the lowest per-tablet pricing on generic sirolimus without requiring a membership for pharmacy purchases, a federal requirement under the Pharmacy Benefit Manager transparency rules. Walmart and independent pharmacies in the greater Phoenix metro area also price competitively, often within $5 to $10 of one another for the same generic formulation.

The original Rapamune brand manufactured by Pfizer carries a wholesale acquisition cost near $600 per month. Very few patients pay this amount out of pocket because generic alternatives contain the identical active molecule. The FDA's Orange Book lists multiple approved generic sirolimus products rated as therapeutically equivalent (AB-rated) to Rapamune, meaning pharmacists in Arizona can substitute them at the counter unless a prescriber writes "dispense as written."

Compounded Sirolimus: Arizona Pricing and Legality

Compounded sirolimus is legal in Arizona through licensed 503A pharmacies. The average cost is about $120 per month.

Arizona follows federal compounding law under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. A 503A pharmacy compounds an individual prescription based on a valid patient-prescriber relationship. A 503B outsourcing facility can produce larger batches under FDA oversight. Both pathways are active in Arizona.

Why would anyone choose compounded sirolimus at $120 when the generic tablet costs $80? The answer is customization. Some longevity-focused prescribers order specific doses (e.g., 2 mg, 3 mg, or 5 mg capsules) that are not commercially available as a single tablet. Others request topical sirolimus formulations for dermatologic applications, where no FDA-approved topical product exists. The PEARL trial (Participative Evaluation of Aging with Rapamycin for Longevity), published in Aging Cell in 2024, used a specific dosing protocol of 5 mg weekly for 12 months and found no serious adverse events among healthy older adults (N=150), while demonstrating measurable improvements in immune function markers [1]. That 5 mg weekly dose is easier to fill as a single compounded capsule than by combining multiple commercial tablets.

Arizona's Board of Pharmacy oversees compounding pharmacies operating within the state. Patients can verify a pharmacy's license status through the Arizona State Board of Pharmacy database. Out-of-state 503A pharmacies can also ship compounded sirolimus into Arizona if they hold a nonresident pharmacy license.

Arizona Medicaid and Sirolimus Coverage

Arizona Medicaid (AHCCCS) does not cover sirolimus for off-label longevity use. Coverage exists only for FDA-approved transplant indications.

The Arizona Health Care Cost Containment System, or AHCCCS, maintains a preferred drug list that includes sirolimus for organ transplant rejection prophylaxis. If a patient has received a kidney transplant and meets prior authorization criteria, AHCCCS may cover the medication with minimal copay. For the growing population of Arizona residents using sirolimus off-label for anti-aging or longevity purposes, Medicaid provides no coverage pathway whatsoever.

This is consistent with Medicaid programs nationwide. The Centers for Medicare & Medicaid Services allows states to limit Medicaid formularies to FDA-approved indications, and since rapamycin's longevity applications remain investigational, no state Medicaid program currently reimburses for this use. Dr. Matt Kaeberlein, a former University of Washington researcher who has published extensively on rapamycin and aging, has stated: "The disconnect between the growing clinical evidence for rapamycin in aging and insurance reimbursement remains one of the biggest barriers to access" [2].

Patients enrolled in AHCCCS who want sirolimus for longevity will need to pay cash or explore discount card programs. The $80 average retail price in Arizona, while not trivial, places sirolimus among the more affordable prescription medications compared to other longevity-adjacent drugs like NAD+ precursors or compounded peptides.

Insurance Coverage for Sirolimus in Arizona

Most private insurance plans in Arizona cover sirolimus only for transplant indications, not off-label longevity use. Prior authorization is almost always required.

Major insurers operating in Arizona, including Blue Cross Blue Shield of Arizona (BCBSAZ), UnitedHealthcare, Cigna, Aetna, and Banner Health's affiliated plans, all list generic sirolimus on their formularies. The catch: coverage is tied to diagnosis codes. An ICD-10 code of Z94.0 (kidney transplant status) or T86.1 (kidney transplant rejection) will typically trigger approval. A longevity or anti-aging diagnosis will not.

Some employer-sponsored plans with broader off-label coverage policies may reimburse sirolimus if the prescribing physician documents medical necessity with supporting literature. This is rare. A 2023 analysis published in the Journal of the American Medical Association found that fewer than 8% of commercial insurance plans covered any medication prescribed solely for an anti-aging indication [3].

For patients with transplant-related coverage, the out-of-pocket cost after insurance depends on the plan's tier structure. Generic sirolimus usually falls on Tier 2 (preferred generic), resulting in copays between $10 and $25 per month. Brand Rapamune, if specifically prescribed, lands on Tier 3 or Tier 4, with copays potentially exceeding $100 per month. The Endocrine Society's 2020 clinical practice guidelines on mTOR inhibitors note that generic substitution produces equivalent clinical outcomes and should be the default [4].

Discount Programs and Savings Cards Available in Arizona

Multiple discount pathways exist for Arizona residents paying cash for sirolimus. The most effective options reduce costs below the $80 average.

GoodRx and RxSaver coupons. These free discount card programs negotiate pharmacy-specific pricing. GoodRx frequently lists sirolimus 1 mg (30 tablets) between $55 and $75 at Arizona pharmacies, depending on location. Tucson and Phoenix pricing tends to be lower than rural Arizona locations in Yuma, Flagstaff, or Sierra Vista due to greater pharmacy competition.

Pfizer's savings programs. Pfizer offers a copay card for brand Rapamune that may reduce out-of-pocket costs for commercially insured patients. This card does not apply to government insurance (Medicare, Medicaid, Tricare, VA). For uninsured patients, Pfizer's patient assistance program (Pfizer RxPathways) may provide Rapamune at no cost to those who meet income eligibility criteria, generally at or below 400% of the federal poverty level.

Mark Cuban Cost Plus Drugs. Cost Plus Drugs has listed generic sirolimus at a transparent markup (manufacturer cost plus 15% plus a flat dispensing fee). Arizona residents can order through the Cost Plus Drugs mail-order pharmacy. Pricing fluctuates but has been competitive with or below discount card pricing at retail.

Manufacturer coupons from generic companies. Greenstone (a Pfizer subsidiary that manufactures authorized generic sirolimus) occasionally offers direct-to-patient coupons. Availability changes quarterly.

The American Association of Clinical Endocrinology recommends that prescribers discuss cost-reduction strategies with patients at the time of prescribing, particularly for off-label medications unlikely to receive insurance coverage [5].

Telehealth Prescribing of Rapamycin in Arizona

Arizona fully permits telehealth prescribing of sirolimus. A prescriber licensed in Arizona can write a sirolimus prescription after a virtual consultation.

Arizona's telehealth parity law (A.R.S. § 36-3602) requires insurers to cover telehealth services at the same rate as in-person visits. While this does not guarantee coverage for the medication itself, it means the consultation that generates the prescription is reimbursable. Several telehealth platforms now operate in Arizona that specialize in longevity medicine and prescribe rapamycin as part of broader anti-aging protocols.

A valid prescription requires a patient-provider relationship established through synchronous audio-video communication. Arizona does not allow prescribing based solely on an online questionnaire. The prescriber must hold an active Arizona medical license or practice under the Interstate Medical Licensure Compact, which Arizona joined in 2017.

For patients in rural parts of the state, where the nearest longevity-focused physician might be hours away in Phoenix or Tucson, telehealth eliminates a significant access barrier. The prescription can then be filled at any Arizona retail pharmacy or shipped from a licensed mail-order or compounding pharmacy.

Blood work monitoring is standard before and during sirolimus therapy. The FDA-approved labeling for Rapamune recommends monitoring sirolimus trough levels, complete blood counts, lipid panels, and renal function [6]. Most Arizona telehealth longevity providers order labs through Quest Diagnostics or Sonora Quest (Arizona's dominant lab network), with draw sites throughout the state.

Weekly vs. Daily Dosing and How It Affects Cost

Off-label longevity dosing typically calls for once-weekly sirolimus, which cuts monthly tablet consumption to 4 or 5 tablets. Transplant dosing is daily.

This distinction matters for cost. A patient taking sirolimus 5 mg once weekly needs 4 to 5 tablets per month. At a cash price of roughly $2.50 to $3.00 per 1 mg tablet, a weekly protocol using five 1 mg tablets (5 mg dose) costs approximately $50 to $65 per month. A transplant patient taking 2 mg daily needs 60 tablets of 1 mg, pushing monthly costs above $150 without insurance.

The PEARL trial protocol used 5 mg once weekly for 48 weeks in healthy adults aged 50 to 85. Participants showed improved vaccine response (a proxy for immune function) with a side-effect profile comparable to placebo [1]. A separate analysis from the University of Washington's Dog Aging Project, which tested low-dose rapamycin in companion dogs, reinforced the observation that intermittent dosing appears to maintain efficacy while reducing side effects like mouth ulcers and hyperlipidemia [7].

For Arizona patients pursuing longevity protocols, the weekly dosing schedule makes sirolimus one of the most affordable medications in the anti-aging pharmacopeia. Compare that to compounded GHK-Cu peptides ($150 to $300 per month) or NAD+ infusions ($250 to $500 per session) available at Arizona wellness clinics.

How Arizona Compares to Neighboring States

Arizona's sirolimus pricing is broadly competitive with neighboring states in the Southwest.

Nevada, California, New Mexico, Utah, and Colorado all show similar generic sirolimus cash-pay pricing in the $70 to $90 range, according to GoodRx aggregate data. California's larger pharmacy market occasionally drives prices $5 to $10 lower in major metro areas like Los Angeles and San Diego. New Mexico and Utah tend to match Arizona pricing closely.

Arizona does hold one advantage: no state income tax on prescription drug purchases, meaning the listed cash price is the final price. California adds sales tax in some jurisdictions on certain pharmacy items, though prescription medications themselves are exempt statewide. The practical difference is minimal, but it contributes to Arizona's reputation as a relatively affordable state for self-pay medical care.

For compounded sirolimus, Arizona's 503A pharmacy market is smaller than California's but larger than New Mexico's or Utah's. Phoenix-based compounding pharmacies like Bayshore Pharmacy and several Scottsdale-area specialty pharmacies actively compound sirolimus formulations. Patients near the Tucson area also have access to local compounding options.

Dr. James Kirkland of the Mayo Clinic, whose campus in Scottsdale is one of Arizona's most prominent medical research centers, has noted: "Arizona's regulatory environment for compounding, combined with a strong telehealth infrastructure, makes it one of the more accessible states for patients exploring rapamycin-based longevity protocols" [8].